Affimed
Affimed is a German immuno-oncology biotechnology company that developed innate cell engager therapies for blood cancers and solid tumors. Affimed N.V. and Affimed GmbH filed for insolvency in May 2025.
Key facts
| Legal Name | Affimed N.V. |
|---|---|
| Company Operating Status | Active |
| Full Address | Technologiepark Im Neuenheimer Feld 582 69120 Heidelberg, Germany |
| Ticker Symbol | AFMD |
| Wellfound ID | affimed-therapeutics |
| Wikidata ID | Q30255337 |
Contact details
Email and phone for Affimed are available to signed-in members of CliffBio.
Sign in to view